Story thread · 4 reports / 3 sources

A CEO With a Proven Track Record of Success in Growing and Scaling Biopharmaceutical Companies Just Appointed CEO at a Clinical-Stage Biotech, Months Before Its Pivotal Phase 3 Readout

financialpost.com · 6dShare

Issued on behalf of Helus Pharma (Nasdaq: HELP) NEW YORK, Aug. 05, 2026 (GLOBE NEWSWIRE) — USA News Group News Commentary – In biotech, the gap between a promising drug and a commercial success is often bridged by a single thing: the operator who has done it before. Helus Pharma (Nasdaq: HELP) (Cboe CA: HELP), […]

First report: Helus Pharma Appoints Michael Halstead as Chief Executive Officer — thestar.com, 8d